The best indicator for Medtronic (MDT)
We backtested 366 indicators across daily, weekly and hourly charts on real Medtronic (MDT) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Donchian 55/20
On the weekly chart, this is the strongest risk-adjusted edge we found for Medtronic (MDT) over ~53.3 years — trailing buy-and-hold by 1.9% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Medtronic (MDT) — trailing buy-and-hold by 3.4% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Donchian 55/20 ✓ | Weekly | 10.2% | 0.57 | -51.4% | 53.3% | 15 | -1.9% |
| 2 | McGinley 100 Trend ✓ | Daily | 12.7% | 0.56 | -57.6% | 18.2% | 33 | 0.5% |
| 3 | Donchian 20 Break ✓ | Weekly | 10.6% | 0.55 | -64.0% | 50.0% | 24 | -1.4% |
| 4 | McGinley 30 Trend ✓ | Weekly | 12.4% | 0.55 | -56.2% | 31.2% | 16 | 0.4% |
| 5 | Ehlers SuperSmoother | Daily | 9.6% | 0.54 | -88.8% | 43.2% | 1821 | -2.6% |
| 6 | Chande Forecast Osc. | Daily | 9.6% | 0.54 | -76.5% | 44.3% | 1527 | -2.6% |
| 7 | Woodie Pivots | Daily | 9.4% | 0.54 | -96.5% | 44.8% | 2873 | -2.8% |
| 8 | McGinley 200 Trend ✓ | Daily | 12.2% | 0.54 | -58.2% | 16.7% | 30 | -0.0% |
| 9 | Swing Index | Daily | 9.2% | 0.53 | -96.7% | 44.5% | 2923 | -3.0% |
| 10 | T3 20/80 Cross ✓ | Daily | 9.1% | 0.53 | -56.3% | 55.3% | 76 | -3.1% |
| 11 | McGinley 100 Trend ✓ | Weekly | 11.7% | 0.53 | -65.5% | 16.7% | 18 | -0.4% |
| 12 | TRIX (21) ✓ | Weekly | 10.5% | 0.53 | -58.8% | 52.6% | 19 | -1.5% |
| 13 | Accumulation Swing Index | Daily | 9.1% | 0.52 | -96.7% | 44.6% | 2926 | -3.1% |
| 14 | QQE ✓ | Weekly | 11.5% | 0.52 | -57.4% | 50.0% | 162 | -0.5% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Medtronic (MDT), Donchian 55/20 on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.